ABDUL KHAN: Open Payments
NPI 1356658116 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$97,686 in 201 payments from 13 companies in 2025. Trend: 2023 $6,404 · 2024 $49,108 · 2025 $97,686
Honoraria: $53,075Speaker / faculty: $29,315Consulting: $5,430Travel & lodging: $5,188Food & beverage: $4,678
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 68 | $55,673 |
| Alkermes, Inc. | 46 | $40,438 |
| Vanda Pharmaceuticals Inc. | 16 | $334 |
| E.R. Squibb & Sons, L.L.C. | 11 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $231 |
| ABBVIE INC. | 13 | $205 |
| Janssen Pharmaceuticals, Inc | 12 | $179 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| Supernus Pharmaceuticals, Inc. | 4 | $79 |
| Otsuka America Pharmaceutical, Inc. | 4 | $74 |
Products named: Auvelity, LYBALVI, FANAPT, COBENFY, CAPLYTA, VRAYLAR, ARISTADA, SPRAVATO.
Industry payments across LA — which companies pay providers there.
